BioCentury
ARTICLE | Clinical News

Xpert Xpress Flu regulatory update

February 16, 2017 8:27 PM UTC

FDA approved the Xpert Xpress Flu from Danaher’s Cepheid subsidiary to diagnose influenza A and B infections. Xpert Xpress Flu is a qualitative PCR-based kit that runs on the company's GeneXpert Syste...

BCIQ Company Profiles

Danaher Corp.